T80.310 ABO incompatibility with acute hemolytic transfusion reaction

Name of the Condition

• ABO incompatibility with acute hemolytic transfusion reaction.

Summary

This condition describes an acute, immune-mediated adverse reaction that occurs when blood or blood products with incompatible ABO antigens are transfused. It is a serious complication characterized by rapid hemolysis of transfused red blood cells, leading to systemic effects such as organ dysfunction and potential life-threatening consequences. The reaction is driven by pre-existing antibodies in the recipient that target antigens on the donor red blood cells, triggering an immediate immune response.

Causes

ABO incompatibility with acute hemolytic transfusion reaction results from the transfusion of blood or blood products containing ABO antigens that do not match the recipient's blood type. This mismatch causes the recipient's antibodies to bind to the donor red blood cells, leading to their destruction (hemolysis). The reaction can occur with red blood cells, plasma, or platelets if ABO compatibility is not maintained during transfusion.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or abdominal pain
• Chest or shoulder pain

Diagnosis

Diagnosis is based on clinical presentation, laboratory findings, and confirmation of incompatible transfusion. Key diagnostic steps include: Review of transfusion history and blood product compatibility. Laboratory tests showing evidence of hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria) Direct antiglobulin test (DAT) to detect antibody-coated red blood cells. Identification of ABO incompatibility through blood typing and crossmatching.

Treatment Options

Treatment focuses on stopping the transfusion immediately, managing hemolysis, and supporting organ function. Interventions may include:

• Administration of intravenous fluids to maintain renal perfusion
• Monitoring and managing electrolyte imbalances
• Use of diuretics to prevent acute kidney injury
• Supportive care for hypotension or respiratory distress
• In severe cases, dialysis or other organ-specific interventions

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timeliness of treatment. Early recognition and intervention can improve outcomes, but severe cases may lead to acute kidney injury, disseminated intravascular coagulation (DIC), or death. Follow-up includes monitoring renal function, hemoglobin levels, and resolution of symptoms. Long-term complications, such as chronic kidney disease, may require ongoing evaluation.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multi-organ dysfunction
• Transfusion-related acute lung injury (TRALI)
• Death (in severe, untreated cases)

Lifestyle & Prevention

Prevention is critical and relies on strict adherence to blood typing, crossmatching, and verification protocols. Key measures include:

• Ensuring accurate ABO typing and crossmatching before transfusion
• Implementing double-check systems for blood product labeling and administration
• Using electronic verification systems to reduce human error
• Training staff on emergency protocols for suspected incompatibility reactions

When to Seek Professional Help

Seek immediate medical attention if symptoms of a transfusion reaction occur, such as fever, chills, flank pain, dark urine, or hypotension, especially during or shortly after a blood transfusion. Prompt evaluation is essential to prevent severe complications.

Tips for Medical Coders

When coding ABO incompatibility with acute hemolytic transfusion reaction (T80.310), ensure documentation supports the acute nature of the reaction and its association with a transfusion event. Verify that the code aligns with the specific clinical scenario, as this code is distinct from unspecified or other types of ABO incompatibility reactions. Accurate documentation of the transfusion context, timing, and clinical findings is essential for proper coding.